Immunotherapy

🎀 Fight.Cure.Win • Patient Guide

Immunotherapy

Immunotherapy—also known as biologic therapy—helps the body’s own immune system recognize and attack cancer cells. It has revolutionized treatment for many cancers, improving survival and quality of life for thousands of people.

How Immunotherapy Works

  • Our immune system naturally patrols for abnormal cells, but cancer can hide by turning “off” immune responses.
  • Immunotherapy drugs work by **reactivating or boosting** immune defenses to target and destroy those cancer cells.
  • Some immunotherapies “mark” cancer cells so the immune system can find them more easily.

Main Types of Immunotherapy

1️⃣ Immune Checkpoint Inhibitors

Block immune “brakes” that cancer uses to hide. These are the most common modern immunotherapies.

  • Examples: nivolumab (Opdivo), pembrolizumab (Keytruda), atezolizumab (Tecentriq).
  • Used in melanoma, lung, kidney, bladder, colorectal (MSI-H), head & neck, cervical, and more.

2️⃣ CAR T-Cell Therapy

A patient’s own T cells are removed, genetically re-engineered in a lab to better attack cancer, and then returned to the body.

  • Used in some leukemias, lymphomas, and multiple myeloma.
  • Given in specialized centers with close monitoring.

3️⃣ Cancer Vaccines

Stimulate the immune system to attack specific cancer-related antigens.

  • Example: Provenge for advanced prostate cancer.
  • Many personalized vaccines are in clinical trials.

4️⃣ Immune System Modulators / Cytokines

Boost overall immune response using signaling proteins such as interferons or interleukins.

  • Used in kidney cancer, melanoma, and others.

How Immunotherapy Is Given

  • Usually delivered by **IV infusion** in an outpatient clinic every 2–6 weeks, depending on the drug.
  • Some treatments are given until disease progression or unacceptable side effects occur.
  • Monitoring continues during and after each infusion to watch for immune-related reactions.

Common Side Effects

Short-Term

  • Fatigue
  • Fever, chills, or flu-like symptoms
  • Skin rash or itching
  • Headache or joint pain
  • Mild nausea or diarrhea

Immune-Related (Autoimmune-Type)

Because immunotherapy activates your immune system, it can sometimes attack healthy tissues.

  • Thyroid or other glands: fatigue, weight change
  • Lungs (pneumonitis): cough, shortness of breath
  • Liver (hepatitis): yellow eyes/skin, abdominal pain
  • Colon (colitis): diarrhea, blood in stool
  • Skin: severe rash or blistering

Most side effects are manageable if caught early. Always report new or unusual symptoms right away—your team may pause therapy and give steroids or other medicines to calm your immune system.

Monitoring & Follow-Up

  • Regular blood tests to check organ function and hormone levels.
  • Scans every few months to track treatment response.
  • Ongoing assessment for delayed immune effects that may appear weeks or months later.

Advantages & Challenges

Potential Benefits

  • Can lead to long-lasting remissions in some cancers.
  • Generally causes fewer long-term toxicities than chemotherapy.
  • Can work even when other treatments have failed.

Limitations

  • Not all cancers respond.
  • Response may take weeks or months (“pseudoprogression” may occur).
  • Immune-related side effects require careful management.
💡 Questions to Ask Your Doctor
  • Is immunotherapy an option for my type and stage of cancer?
  • Which drug or combination will I receive, and how does it work?
  • How often will I need treatments and scans?
  • What immune-related side effects should I look out for?
  • Are there clinical trials I should consider?

Real-World Examples

  • Melanoma: Checkpoint inhibitors have turned advanced melanoma into a treatable disease for many patients.
  • Lung cancer: Adding PD-1/PD-L1 inhibitors to chemo improved survival and became standard care.
  • Blood cancers: CAR T-cell therapy has achieved complete remissions in leukemia, lymphoma, and myeloma.

Your care team will decide if immunotherapy fits your cancer type, genetic profile, and overall health. Genetic and biomarker testing (e.g., PD-L1, MSI-H, TMB) often guides eligibility.

Learn more at the National Cancer Institute